Information:
Fel:
ID
12930
Beskrivning
Study of the Effectiveness of Additional Reductions in Cholesterol and Homocysteine; ODM derived from: https://clinicaltrials.gov/show/NCT00124072
Länk
https://clinicaltrials.gov/show/NCT00124072
Nyckelord
Versioner (1)
- 2016-01-06 2016-01-06 -
Rättsinnehavare
CC BY-NC 3.0
Uppladdad den
6 januari 2016
DOI
För en begäran logga in.
Licens
Creative Commons BY-NC 3.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Eligibility Cardiovascular Disease NCT00124072
Eligibility Cardiovascular Disease NCT00124072
- StudyEvent: Eligibility
Similar models
Eligibility Cardiovascular Disease NCT00124072
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
prior myocardial infarction
Item
prior myocardial infarction
boolean
C0027051 (UMLS CUI [1])
statin therapy
Item
statin therapy indicated
boolean
C0360714 (UMLS CUI [1])
folic acid
Item
no clear indication for folic acid
boolean
C0016410 (UMLS CUI [1])
no clear contraindication to study treatments
Item
no clear contraindication to study treatments
boolean
C0087111 (UMLS CUI [1])
cholesterol
Item
screening plasma total cholesterol <3.5 mmol/l in patient already on statin therapy, or <4.5 mmol/l in patient not on statin therapy
boolean
C1445957 (UMLS CUI [1])
chronic liver disease
Item
chronic liver disease
boolean
C0341439 (UMLS CUI [1])
renal disease
Item
severe renal disease or evidence of renal impairment
boolean
C0022658 (UMLS CUI [1])
inflammatory muscle disease
Item
inflammatory muscle disease
boolean
C0026848 (UMLS CUI [1])
fibrates or high-dose niacin
Item
concurrent treatment with fibrates or high-dose niacin
boolean
C1449704 (UMLS CUI [1])
C0027996 (UMLS CUI [2])
C0027996 (UMLS CUI [2])
concurrent treatment with cyclosporin (or condition likely to result in organ transplantation and the need for cyclosporin), nefazodone, methotrexate, systemic azole antifungal or systemic macrolide antibiotics
Item
concurrent treatment with cyclosporin (or condition likely to result in organ transplantation and the need for cyclosporin), nefazodone, methotrexate, systemic azole antifungal or systemic macrolide antibiotics
boolean
C0010592 (UMLS CUI [1])
C0068485 (UMLS CUI [2])
C0025677 (UMLS CUI [3])
C0004504 (UMLS CUI [4])
C0003240 (UMLS CUI [5])
C0068485 (UMLS CUI [2])
C0025677 (UMLS CUI [3])
C0004504 (UMLS CUI [4])
C0003240 (UMLS CUI [5])
child bearing potential
Item
child bearing potential
boolean
C0015895 (UMLS CUI [1])
no other predominant medical problem (other than coronary heart disease [chd]) which might limit compliance with 5 years of study treatment
Item
no other predominant medical problem (other than coronary heart disease [chd]) which might limit compliance with 5 years of study treatment
boolean
C1321605 (UMLS CUI [1,1])
C0439801 (UMLS CUI [1,2])
C0009488 (UMLS CUI [1,3])
C0439801 (UMLS CUI [1,2])
C0009488 (UMLS CUI [1,3])